Citation

Kamunkhwala Gausi, Lubbe Wiesner, Jennifer Norman, Carole L Wallis, Carolyne Onyango-Makumbi, Tsungai Chipato, David W Haas, Renee Browning, Nahida Chakhtoura, Grace Montepiedra, Lisa Aaron, Katie McCarthy, Sarah Bradford, Tichaona Vhembo, Lynda Stranix-Chibanda, Gaerolwe R Masheto, Avy Violari, Blandina T Mmbaga, Linda Aurpibul, Ramesh Bhosale, Neetal Nevrekhar, Vanessa Rouzier, Enid Kabugho, Mercy Mutambanengwe, Vongai Chanaiwa, Mandisa Nyati, Tsungai Mhembere, Fuanglada Tongprasert, Anneke Hesseling, Katherine Shin, Bonnie Zimmer, Diane Costello, Patrick Jean-Philippe, Timothy R Sterling, Gerhard Theron, Adriana Weinberg, Amita Gupta, Paolo Denti, IMPAACT P1078 (TB APPRISE) Study Group Team. Pharmacokinetics and Drug-Drug Interactions of Isoniazid and Efavirenz in Pregnant Women Living With HIV in High TB Incidence Settings: Importance of Genotyping. Clinical Pharmacology & Therapeutics. 2020. PMID: 32909316

Citation

G Theron, S Brummel, L Fairlie, M Pinilla, K McCarthy, M Owor, L Chinula, B Makanani, A Violari, D Moodley, N Chakhtoura, R Browning, R Hoffman, MG Fowler for the PROMISE 1077BF/1077FF Teams. Pregnancy outcomes of women conceiving on antiretroviral therapy (ART) compared to those commenced on ART during pregnancy. Clinical Infectious Diseases. 2020. ciaa805PMID: 32564058

Citation

DL Jacobson, JC Lindsey, C Gordon, R Hazra, H Spiegel, J Benson, GK Siberry, IMPAACT P1076 Study Team. Alendronate improves bone mineral density in perinatally HIV-Infected children and adolescents with low bone mineral density for age.. Clinical Infectious Diseases. 2020. 71: 1281-1288. PMID: 31573608

Citation

K Angelidou, MG Fowler, P Flynn, A Coletti, K McCarthy, R Browning, J McIntyre, S Brummel, D Shapiro, C Tierney for the PROMISE study team. Enrollment and Transition Challenges in the International Maternal Pediatric and Adolescent AIDS Clinical Trials (IMPAACT) Network’s PROMISE Trial for Resource-Limited Regions. Clinical Trials. 2020. 17: 437-447. PMID: 32191142

Citation

CK Cunningham, EJ McFarland, RL Morrison, EV Capparelli, JT Safrit, LM Mofenson, B Mathieson, ME Valentine, C Perlowski, B Smith, R Hazra, L Purdue, P Muresan, PA Harding, T Mbengeranwa, LG Robinson, A Wiznia, G Theron, B Lin, RT Bailer, JR Mascola, BS Graham, IMPAACT P1112 team. Safety, Tolerability, and Pharmacokinetics of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 in HIV-Exposed Newborn Infants. Journal of Infectious Diseases. 2020. 222: 628-636. PMID: 31681963

Citation

Elizabeth J. McFarland, Ruth A. Karron, Petronella Muresan, Coleen K. Cunningham, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva, Patrick Jean-Philippe, Jack Moye Jr, Elizabeth Schappell, Emily Barr, Vivian Rexroad, Laura Fearn, Mikhaela Cielo, Andrew Wiznia, Jaime G. Deville, Lijuan Yang, Cindy Luongo, Peter L.Collins, Ursula J. Buchholz. Live-attenuated respiratory syncytial virus vaccine with M2-2 deletion and with SH non-coding region is highly immunogenic in children. Journal of Infectious Diseases. 2020. 221: 2050-2059. PMID: 32006006

Citation

Christina Zuend, Nicole Tobin, Trisha Vera, Lani Kotyrba, Laura Noel-Romas, Kenzie Birse, Sarah Mutch, Fan Li, David Lee, Stuart McCorrister, Garrett Westmacott, Grace Aldrovandi, Adam Burgner. Pregnancy associates with alterations to the host and microbial proteome in vaginal mucosa. American Journal of Reproductive Immunology. 2020. 83: e13235. PMID: 32196803

Citation

N Higa, A Pelz, D Birch, AI Beck, P Samson, M Bwakura-Dangarembizi, C Bolton-Moore, E Capparelli, E Chadwick, LM Frenkel. Association of Virologic Failure and Nonnucleoside Reverse Transcriptase Inhibitor Resistance Found in Antiretroviral-Naive Children Infected With Human Immunodeficiency Virus and Given Efavirenz-Based Treatment.. Journal of the Pediatric Infectious Diseases Society. 2020. 9: 261-264. PMID: 31194860

Citation

Diana Clarke, Edward Acosta, Mae Cababasay, Jiajia Wang, Anne Chain, Hedy Teppler, Stephanie Popson, Bobbie Graham, Betsy Smith, Rohan Hazra, Kat Calabrese, Yvonne Bryson, Stephen Spector, Jos Lommerse, Mark Mirochnick, IMPAACT P1110 Protocol Team. Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1-Exposed Neonates at Risk of Infection (IMPAACT P1110). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 2020. 84: 70-7. PMID: 31913995

Citation

Esaú C João, R Leavitt Morrison, David E Shapiro, Nahida Chakhtoura, Maria Isabel S Gouvèa, Maria de Lourdes B Teixeira, Trevon L Fuller, Blandina T Mmbaga, James S Ngocho, Boniface N Njau, Avy Violari, Ruth Mathiba, Zaynab Essack , Jose Henrique S Pilotto, Luis Felipe Moreira, Maria Jose Rolon, Pedro Cahn, Sinart Prommas , Timothy R Cressey, Kulkanya Chokephaibulkit, Peerawong Werarak, Lauren Laimon, Roslyn Hennessy , Lisa M Frenkel , Patricia Anthony, Brookie M Best, George K Siberry, Mark Mirochnick. Raltegravir Versus Efavirenz in Antiretroviral-Naive Pregnant Women Living With HIV (NICHD P1081): An Open-Label, Randomised, Controlled, Phase 4 Trial. Lancet HIV. 2020. 7: e322-e331. PMID: 32386720